Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,238 | -47,056 | -32,875 | -15,169 | -61,431 |
| Depreciation Amortization | 661 | 504 | 340 | 171 | 502 |
| Accounts payable and accrued liabilities | 221 | 518 | 57 | -266 | 516 |
| Other Working Capital | 33 | -2,067 | -3,364 | -4,659 | 4,060 |
| Other Operating Activity | 10,554 | 7,848 | 5,507 | 3,367 | 8,929 |
| Operating Cash Flow | $-51,769 | $-40,253 | $-30,335 | $-16,556 | $-47,424 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -24 | -24 | -24 | -2,075 |
| Investing Cash Flow | $-24 | $-24 | $-24 | $-24 | $-2,075 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,438 | 20,438 | 20,438 | 19,688 | 1,250 |
| Debt Repayment | -10,213 | -10,213 | -10,213 | -10,213 | N/A |
| Common Stock Issued | 50,703 | 351 | 198 | 198 | 137,766 |
| Common Stock Repurchased | -167 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -683 | -683 | -683 | -546 | -3,325 |
| Financing Cash Flow | $60,078 | $9,893 | $9,740 | $9,127 | $135,691 |
| Exchange Rate Effect | -30 | -29 | -25 | -22 | -11 |
| Beginning Cash Position | 168,729 | 168,729 | 168,729 | 168,729 | 82,548 |
| End Cash Position | 176,984 | 138,316 | 148,085 | 161,254 | 168,729 |
| Net Cash Flow | $8,255 | $-30,413 | $-20,644 | $-7,475 | $86,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,769 | -40,253 | -30,335 | -16,556 | -47,424 |
| Capital Expenditure | -24 | -24 | -24 | -24 | -2,075 |
| Free Cash Flow | -51,793 | -40,277 | -30,359 | -16,580 | -49,499 |